PSA
56
3
LH
40
-5
MTCH
20
-8
LUV
45
-2
UPS
48
2
ADM
28
3
VRSK
68
-12
DD
53
-6
AN
50
-5
ICE
59
-3
KR
36
-6
USB
50
-3
AMT
37
3
ACN
47
-5
STZ
52
-6
DVN
14
-6
HUM
41
-4
MCD
52
-5
VNO
46
-13
NAVI
52
-2
PSA
56
3
LH
40
-5
MTCH
20
-8
LUV
45
-2
UPS
48
2
ADM
28
3
VRSK
68
-12
DD
53
-6
AN
50
-5
ICE
59
-3
KR
36
-6
USB
50
-3
AMT
37
3
ACN
47
-5
STZ
52
-6
DVN
14
-6
HUM
41
-4
MCD
52
-5
VNO
46
-13
NAVI
52
-2
Financhill
Back

CSPC Pharmaceutical Group 10K Form

Sell
27

CSPCY
CSPC Pharmaceutical Group

Last Price:
2.61
Seasonality Move:
4.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CSPCY News And Ratings

See the #1 stock for the next 7 days that we like better than CSPCY

CSPCY Financial Statistics

Sales & Book Value

Annual Sales: $4.45B
Cash Flow: $0
Price / Cash Flow: 35.44
Annual Sales: $1.63
Price / Book: 1.58

Profitability

Net Income (TTM): $0
Gross Margin: $3.14B
Return on Equity: 16.82%
Return on Assets: 14.32%

CSPC Pharmaceutical Group Earnings Forecast

Key CSPC Pharmaceutical Group Financial Ratios

  • The Gross Profit Margin over the past 21 years for CSPCY is 70.51%.
  • The Selling, General & Administrative Expenses for CSPCY have been equal to 32.85% of Gross Profit Margin.
  • The Research & Development expenses have been 15.36% of Revenue.
  • The Interest Expense is 0.44% of Operating Income.
  • The Net Earning history of CSPCY is 18.68% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 14 years.

CSPC Pharmaceutical Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CSPCY
Website: cspc.com.hk

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 2.54
Quick Ratio: 2.2

Price-to-Earnings

Trailing P/E Ratio: 9.33
Forward P/E Ratio: 0

CSPCY Technical Analysis vs Fundamental Analysis

Sell
27
CSPC Pharmaceutical Group (CSPCY) is a Sell

Is CSPC Pharmaceutical Group a Buy or a Sell?